Corporate Environmental Responsibility: A Case on ITC Limited

Case Title:

Eli Lilly's Pre-clinical Research Practices: A Controversial Issue?

Abstract:
Eli Lilly, one of the leading pharmaceutical companies in the US, attracted faced allegations when it decided to outsource its pre-clinical research practices to China. (PETA) People for the Ethical Treatment of Animals (PETA) alleged that the company had outsourced its pre-clinical trials to China only to bypass the stringent animal welfare laws prevalent in the US. PETA felt that the company was indulging in severe cruelty measures and thereby filed a resolution against the company in the mid-2000s asking for suitable explanations from the company. The company, on the other hand, claimed that it did not treat animals cruelly. Moreover, the company stated that it had outsourced animal testing procedures to China to save costs and lower its expenses.

Pedagogical Objectives:

• To understand the significance of the pre-clinical trials in the drug development process.
• To analyse the allegations raised by PETA against Eli Lilly.
• To analyse the controversies, which resulted between Eli Lilly and PETA regarding the outsourcing decision.

Keywords :  Clinical trials, Outsourcing, Animal dealers, Drug development process, (PETA) People for the Ethical Treatment of Animals, Ethical codes, Animal cruelty, Unethical practices, China, Pharmaceutical companies, Therapeutic benefits